LYON, France--(BUSINESS WIRE)--Poxel SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat type 2 diabetes, today announced that Jonae R. Barnes has joined the Company as Senior Vice President, Investor Relations and Public Relations. Ms. Barnes will be based in the Boston area, a leading area in drug development and innovation.
